Delaware | 001-37844 | 81-0980861 | ||||||||||||
(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (IRS Employer Identification Number) | ||||||||||||
4721 Emperor Boulevard, Suite 100, Durham, North Carolina | 27703 | |||||||||||||
(Address of principal executive offices) | (Zip Code) | |||||||||||||
Mike Crowe, Senior Vice President—Operations; (919) 474-6700 | ||||||||||||||
(Name and telephone number, including area code, of the person to contact in connection with this report) |
X | Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2024 | |||||||
Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended _______. |
BIOVENTUS INC. | |||||||||||
Date: June 2, 2025 | By: | /s/ Mike Crowe | |||||||||
Mike Crowe, Senior Vice President—Operations |